Repositorio Dspace

Effect of NAC treatment and physical activity on neuroinflammation in subchronic Parkinsonism; is physical activity essential?

Mostrar el registro sencillo del ítem

dc.contributor.author Gil-Martínez, Ana-Luisa
dc.contributor.author Cuenca, Lorena
dc.contributor.author Sánchez, Consuelo
dc.contributor.author Estrada, Cristina
dc.contributor.author Fernández-Villalba, Emiliano
dc.contributor.author Herrero, María-Trinidad
dc.date.accessioned 2026-01-19T16:03:19Z
dc.date.available 2026-01-19T16:03:19Z
dc.date.issued 2018-11-26
dc.identifier.citation Gil-Martínez AL, Cuenca L, Sánchez C, Estrada C, Fernández-Villalba E, Herrero MT. Effect of NAC treatment and physical activity on neuroinflammation in subchronic Parkinsonism; is physical activity essential? J Neuroinflammation. diciembre de 2018;15(1):328.
dc.identifier.issn 1742-2094
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/23679
dc.description.abstract BACKGROUND: Neuroprotective strategies are becoming relevant to slow down dopaminergic cell death and inflammatory processes related to the progressive neurodegeneration in Parkinson's disease (PD). Interestingly, among others, physical activity (PA) or anti-oxidant agents (such as N-acetyl-L-cysteine, NAC) are common therapeutic strategies. Therefore, this study aims to analyze if there is a synergistic effect of physical activity along with NAC treatment on dopaminergic degeneration and neuroinflammatory response in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism model after subchronic intoxication. METHODS: To ascertain this possibility, 48 8-week-old male mice (C57BL/6 strain) were used. Twenty four of them were placed individually in cages where voluntary physical activity was automatically monitored during 30 days and were divided into groups: (i) control; (ii) NAC; (iii) MPTP, and (iv) MPTP+NAC. The other 24 mice were divided into the same four groups but without physical activity. RESULTS: The data collected during the treatment period showed that there was an overall increase in the total running distance in all groups under physical activity, including Parkinsonian animals. However, the monitoring data per day showed that the activity routine by MPTP and MPTP+NAC groups was disrupted by alterations in the circardian rhythm because of MPTP intoxication. Results from post-mortem studies in the substantia nigra pars compacta (SNpc) showed significant decrease in the number of TH+ cells in all MPTP groups. Moreover, TH+ expression in the striatum was significantly decreased in all MPTP groups. Thus, PA + NAC treatment do not protect dopaminergic neurons against a subchronic intoxication of MPTP. Regarding glial response, the results obtained from microglial analysis do not show significant increase in the number of Iba-1+ cell in MPTP+NAC and MPTP+PA + NAC. In the striatum, a significant decrease is observed only in the MPTP+NAC group compared with that of the MPTP group. The microglial results are reinforced by those obtained from the analysis of astroglial response, in which a decrease in the expression of GFAP+ cells are observed in MPTP+NAC and MPTP+PA + NAC compared with MPTP groups both in the SNpc and in the striatum. Finally, from the study of the astroglial response by the co-localization of GFAP/S100b, we described some expression patterns observed based on the severity of the damage produced by the MPTP intoxication in the different treated groups. CONCLUSIONS: These results suggest that the combination of physical activity with an anti-oxidant agent does not have a synergistic neuroprotective effect in the nigrostriatal pathway. Our results show a potential positive effect, only due to NAC treatment, on the neuroinflammatory response after subchronic MPTP intoxication. Thus, physical activity is not essential, under these conditions. However, we believe that physical activity, used for therapeutic purposes, has a beneficial long-term effect. In this line, these results open the door to design longer studies to demonstrate its promising effect as neuroprotective strategy.
dc.language.iso eng
dc.publisher BMC
dc.rights Atribución/Reconocimiento 4.0 Internacional
dc.rights.uri https://creativecommons.org/licenses/by/4.0/deed.es *
dc.subject.mesh 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine/pharmacology
dc.subject.mesh Acetylcysteine/therapeutic use
dc.subject.mesh Analysis of Variance
dc.subject.mesh Animals
dc.subject.mesh Calcium-Binding Proteins/metabolism
dc.subject.mesh Disease Models, Animal
dc.subject.mesh Encephalitis/drug therapy/etiology/pathology/rehabilitation
dc.subject.mesh Glial Fibrillary Acidic Protein/metabolism
dc.subject.mesh Imaging, Three-Dimensional
dc.subject.mesh Male
dc.subject.mesh Mice
dc.subject.mesh Mice, Inbred C57BL
dc.subject.mesh Microfilament Proteins/metabolism
dc.subject.mesh Microscopy, Confocal
dc.subject.mesh Neuroprostanes/therapeutic use
dc.subject.mesh Parkinsonian Disorders/chemically induced/complications
dc.subject.mesh Physical Conditioning, Animal/methods/physiology
dc.subject.mesh S100 Calcium Binding Protein beta Subunit/metabolism
dc.subject.mesh Substantia Nigra/drug effects/pathology
dc.subject.mesh Time Factors
dc.subject.mesh Tyrosine 3-Monooxygenase/metabolism
dc.title Effect of NAC treatment and physical activity on neuroinflammation in subchronic Parkinsonism; is physical activity essential?
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 30477535
dc.relation.publisherversion https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-018-1357-4
dc.type.version info:eu-repo/semantics/publishedVersion
dc.identifier.doi 10.1186/s12974-018-1357-4
dc.journal.title Journal of Neuroinflammation


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento 4.0 Internacional Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento 4.0 Internacional

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta